Abstract:Aspergillus fumigatus is the major filamentous fungal pathogen in humans. The gold standard treatment of A. fumigatus is based on azole drug use, but the appearance of azole-resistant isolates is increasing at an alarming rate. The cyp51A gene encodes the enzymatic target of azole drugs, and azole-resistant alleles of cyp51A often have an unusual genetic structure containing a duplication of a 34- or 46-bp region in the promoter causing enhanced gene transcription. These tandem repeats are called TR34 and TR46 and produce duplicated binding sites for the SrbA and AtrR transcription factors. Using site-directed mutagenesis, we demonstrate that both the SrbA (sterol response element [SRE]) and AtrR binding sites (AtrR response element [ATRE]) are required for normal cyp51A gene expression. Loss of either the SRE or ATRE from the distal 34-bp repeat of the TR34 promoter (further 5' from the transcription start site) caused loss of expression of cyp51A and decreased voriconazole resistance. Surprisingly, loss of these same binding sites from the proximal 34- or 46-bp repeat led to increased cyp51A expression and voriconazole resistance. These data indicate that these duplicated regions in the cyp51A promoter function differently. Our findings suggest that the proximal 34- or 46-bp repeat in cyp51A recruits a corepressor that requires multiple factors to act while the distal repeat is free of this repression and provides the elevated cyp51A expression caused by these promoter duplications. IMPORTANCE Aspergillus fumigatus is the most common human filamentous fungal pathogen. Azole drugs are the current therapy of choice for A. fumigatus, but the prevalence of azole resistance is increasing. The main genetic alteration causing azole resistance is a change in the cyp51A gene, which encodes the target of these drugs. Azole-resistant cyp51A alleles routinely contain duplications in their promoter regions that cause increased gene transcription. Here, we demonstrate that clinical isolates containing a 34- or 46-bp duplication in the cyp51A promoter required the presence of the transcription factor-encoding atrR gene to exhibit elevated azole resistance. Eliminations of transcription factor binding sites in the cyp51A gene have differential actions on expression of the resulting mutant allele. These data dissect the molecular inputs to cyp51A transcription and reveal a complicated function of the promoter of this gene that is critical in azole resistance.

Antifungal Susceptibility of the A.fumigatus Transformants Containing Extra Copies of A.flavus Cyp51 Gene Homologues to the Common Antifungal Drugs

Mutation in Cyp51a and High Expression of Efflux Pump Gene of Aspergillus Fumigatus Induced by Propiconazole in Liquid Medium and Soil.

Increased Triazole-Resistance and Cyp51a Mutations in Aspergillus Fumigatus after Selection with a Combination of the Triazole Fungicides Difenoconazole and Propiconazole

Molecular mechanisms of cross-resistance to azole antifungal agents in a clinical isolate of Aspergillus fumigatus: a preliminary study

Investigation of Azole Resistance Involving cyp 51A and cyp 51B Genes in Clinical Aspergillus flavus Isolates

Uncovering New Mutations Conferring Azole Resistance in the Aspergillus Fumigatus Cyp51a Gene.

In vitro antifungal susceptibility profile and genotypic characterization of clinical Aspergillus isolates in Eastern China on behalf of Eastern China Invasive Fungi Infection Group (ECIFIG)

Mutations in the Cyp51A Gene and Susceptibility to Itraconazole in Aspergillus Fumigatus Isolated from Avian Farms in France and China

Mutations in the Cyp51a Gene and Susceptibility to Itraconazole in Aspergillus Fumigatus Serially Isolated from A Patient with Lung Aspergilloma

The T788G Mutation in the Cyp51c Gene Confers Voriconazole Resistance in Aspergillus Flavus Causing Aspergillosis.

Cyp51a-Based Mechanism of Azole Resistance in Aspergillus Fumigatus: Illustration by A New 3d Structural Model of Aspergillus Fumigatus Cyp51a Protein

Multiple cyp51A-Based Mechanisms Identified in Azole-Resistant Isolates of Aspergillus fumigatus from China.

A ubiquitin-mediated post-translational degradation of Cyp51A contributes to a novel azole resistance mode in Aspergillus fumigatus

Differential Functions of Individual Transcription Factor Binding Sites in the Tandem Repeats Found in Clinically Relevant cyp51A Promoters in Aspergillus fumigatus

Preliminary study on the susceptibility of a polyene-resistant Aspergillus flavus strain to common antifungal drugs

Phenotype Analysis of Aspergillus Fumigatus Containing Extra Copies of ERG3B Gene

Susceptibility testing of Aspergillus biofilms against common antifungal drugs and a preliminary study on molecular mechanisms of antifungal drug resistance in Aspergillus biofilms

Molecular identification and antifungal susceptibility in clinical isolates of Aspergillus species

In Vitro Activity of Isavuconazole and Other Mould-Active Azoles against Aspergillus fumigatus with and without CYP51 Alterations

Screening and Characterization of a Non- Cyp51a Mutation in an Aspergillus Fumigatus Cox10 Strain Conferring Azole Resistance

Triazole phenotypes and genotypic characterization of clinical <i&g